Oramed Pharmaceuticals Inc.

Major Shareholding Notification • Nov 21, 2018

SEC Form 3

FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

OMB APPROVAL OMB Number: 3235-0104 Estimated average burden hours per response: 0.5

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

* 1. Name and Address of Reporting Person Hasleton Mark Daniel			2. Date of Event Requiring Statement (Month/Day/Year)		3. Issuer Name and Ticker or Trading Symbol ORAMED PHARMACEUTICALS INC. [ ORMP ]
(Last) P.O. BOX 39098 (Street) JERUSALEM L3 (City)	(First) HI-TECH PARK 2/4 GIVAT-RAM, (State)	(Middle) 91390 (Zip)	11/15/2018		X	4. Relationship of Reporting Person(s) to Issuer (Check all applicable) Director Officer (give title below) VP Business Development	10% Owner Other (specify below)		X	(Month/Day/Year) Applicable Line) Person Reporting Person	5. If Amendment, Date of Original Filed 6. Individual or Joint/Group Filing (Check Form filed by One Reporting Form filed by More than One
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)					2. Amount of Securities 3. Ownership Beneficially Owned (Instr. 4) Form: Direct (D) or Indirect (I) (Instr. 5)		4. Nature of Indirect Beneficial Ownership (Instr. 5)
Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)			2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)			4. or	Conversion	5. Ownership Form:	6. Nature of Indirect Beneficial Ownership (Instr. 5)
			Date Exercisable	Expiration Date	Title		Amount or Number of Shares	Exercise Price of Derivative Security		Direct (D) or Indirect (I) (Instr. 5)

Explanation of Responses:

No securities are beneficially owned.

/s/ Mark Hasleton 11/20/2018

** Signature of Reporting Person Date

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.